Becton, Dickinson and Company · Class II · Cleared Jan 5, 2018
| K-number | K173252 |
| Device name | BD Phoenix Automated Microbiology System - GN Ceftolozane/tazobactam (0.25/4-32/4 ug/mL) |
| Applicant | Becton, Dickinson and Company |
| Product code | LON |
| Device class | Class II |
| Decision date | Jan 5, 2018 |
| Decision | Substantially Equivalent |
| Regulation | 866.1645 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov